News
New data shows continued growth in advanced therapy clinical trials in the UK for 2025, with the number of early-stage trials remaining high
The number of ongoing advanced therapy clinical trials in the UK reached 193 in 2025, with 56% being early-stage trials, and 80% being commercially sponsored. The data is presented today in the Cell and Gene Therapy Catapult’s (CGT Catapult) UK 2025 Advanced Therapy Medicinal Product (ATMP) Clinical Trials Database.